Note: Ingredients listed on restricted chemical lists
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2011-05-06
Product name
ATIVAN
Chemical name
Benzodiazepine
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: White crystalline powder
Signal word
WARNING
Hazard statements
Suspected of damaging the unborn child. May cause harm to breastfed babies.
Additional information
Known Clinical Effects: Adverse effects most commonly reported in clinical use include sedation, dizziness, weakness, clumsy motion of limbs/trunk (ataxia), incoordination, fatigue, drowsiness, amnesia, confusion, state of intense good feeling (euphoria), suicidal behavior. Benzodiazepines may cause fetal damage when administered during pregnancy. Secreted in human breast milk. EU Indication of danger: Toxic to Reproduction: Category 2 EU Hazard Symbols: EU Risk Phrases: R61 - May cause harm to the unborn child. R64 - May cause harm to breastfed babies. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
